<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2013091114634N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2013-12-09</date_registration>
      <primary_sponsor>Vice chancellor for research, Qazvin University of Medical Sciences</primary_sponsor>
      <public_title>Effect of warm footbath on arteriovenous fistula puncture-related pain in hemodialysis patients</public_title>
      <acronym></acronym>
      <scientific_title>Effect of warm footbath with and without vibration on arteriovenous fistula puncture-related pain in hemodialysis patients at educational - medical hospitals of Qazvin.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2013-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>31</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/14213</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Supportive.</study_design>
      <phase>2</phase>
      <hc_freetext>Arteriovenous fistula puncture-related pain in hemodialysis patients.</hc_freetext>
      <i_freetext>This research will be an experimental study of the clinical trial with pre-test - post-test method with one group. After learning how to use a pain ruler to Samples, pain assessment will be performed by it. At first pain intensity measurement of all cases will be performed during the six intermittent hemodialysis sessions without intervention then it will be two weeks time interval. In the next step during the six intermittent hemodialysis sessions warm footbath with vibration done and the pain will be assessed after the intervention then it will be two weeks time interval again. In the final step during the six intermittent hemodialysis sessions warm footbath without vibration done and the pain will be assessed after the intervention. In both methods of intervention samples in the supine position with bending the knees will submerge their legs into the warm water. Legs will be submerged above the ankle in the 40 ± 2 ° C water for ten minutes. Embedding fistula needles will be ten minutes after the start of the intervention and immediately after that, the patient will be asked to determine the number of pain intensity on pain ruler. After the intervention, the patient's feet will be dry with a disposable towel. In the first method warm footbath with vibration will be done by using footbath massager machine made in Germany. The device is adjustable and constant water temperature of 40 ± 2 ° C is the same as it is able to induce vibrations in the water. It should be noted that the device is not for personal use and it is washable and disinfection after each use, which will be done after each intervention. In the second method warm footbath without vibration will be done by using a plastic pan and pouring the 40 ± 2 ° C water inside it. Initially as a pilot the 40 ± 2 ° C water will be poured into plastic pan and its temperature will be measured continuously for ten minutes until the water temperature drops be determined then by removing amounts of water from the pan and adding the same amount of warm water, amount of water that must be added and removed during the study and the time required will be determined as the temperature of the water in the plastic pan is kept constant at 40 ± 2 ° C. For all samples, the same size and shape of the plastic pans will be used. Plastic pan also will be washed and disinfected after each intervention. Water temperature will be measured by a standard mercury thermometer..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Abbas Ali Madadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3419759811</zip>
        <telephone>+98 28 1333 8127</telephone>
        <email>Zabbasalimadadi@qums.ac.ir</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Jalil Azzimian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3419759811</zip>
        <telephone>+98 28 1333 8127</telephone>
        <email>azzimianj@yahoo.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Major inclusion criteria: having an arteriovenous fistula; absence of evidence of peripheral vascular disease; no wounds to both legs above the ankle area; there is no impairment of consciousness and knowledge of the time and place and person; the ability to communicate verbally and audio; having age between 17-65 years;  the last three months of fistula placement; no history of diabetes; no history of sensory and neurological disorders; Lack of consistent use of the substance, drug or relieve method to be effective on pain of fistula Needles. &#13;
Major exclusion criteria: No need to go on hemodialysis; patients travel long; kidney transplantation; lack of consent to continue to participate in the study; the patient dies; if the patient is reported any other pain at evaluation or intervention time and or used of the substance, drug or relieve method which be effective on pain of Fistula Needles, excluded from the dialysis session and the next session will be enrolled in the study again but if this process is repeated in several sessions the patient will be completely excluded.</inclusion_criteria>
      <agemin>17 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T82.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mechanical complication of vascular dialysis catheter</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>This research will be an experimental study of the clinical trial with pre-test - post-test method with one group. After learning how to use a pain ruler to Samples, pain assessment will be performed by it. At first pain intensity measurement of all cases will be performed during the six intermittent hemodialysis sessions without intervention then it will be two weeks time interval. In the next step during the six intermittent hemodialysis sessions warm footbath with vibration done and the pain will be assessed after the intervention then it will be two weeks time interval again. In the final step during the six intermittent hemodialysis sessions warm footbath without vibration done and the pain will be assessed after the intervention. In both methods of intervention samples in the supine position with bending the knees will submerge their legs into the warm water. Legs will be submerged above the ankle in the 40 ± 2 ° C water for ten minutes. Embedding fistula needles will be ten minutes after the start of the intervention and immediately after that, the patient will be asked to determine the number of pain intensity on pain ruler. After the intervention, the patient's feet will be dry with a disposable towel. In the first method warm footbath with vibration will be done by using footbath massager machine made in Germany. The device is adjustable and constant water temperature of 40 ± 2 ° C is the same as it is able to induce vibrations in the water. It should be noted that the device is not for personal use and it is washable and disinfection after each use, which will be done after each intervention. In the second method warm footbath without vibration will be done by using a plastic pan and pouring the 40 ± 2 ° C water inside it. Initially as a pilot the 40 ± 2 ° C water will be poured into plastic pan and its temperature will be measured continuously for ten minutes until the water temperature drops be determined then by removing amounts of water from the pan and adding the same amount of warm water, amount of water that must be added and removed during the study and the time required will be determined as the temperature of the water in the plastic pan is kept constant at 40 ± 2 ° C. For all samples, the same size and shape of the plastic pans will be used. Plastic pan also will be washed and disinfected after each intervention. Water temperature will be measured by a standard mercury thermometer.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: In every hemodialysis session. Method of measurement: By using a numerical pain intensity scale (pain ruler).</prim_outcome>
      <prim_outcome>Footbath with vibration method. Timepoint: Six intermittent hemodialysis sessions. Method of measurement: Method mentions in the information form.</prim_outcome>
      <prim_outcome>Footbath without vibration method. Timepoint: Six intermittent hemodialysis sessions. Method of measurement: Method mentions in the information form.</prim_outcome>
      <prim_outcome>Age. Timepoint: First meeting of evaluation. Method of measurement: Based on year in the information form.</prim_outcome>
      <prim_outcome>Sex. Timepoint: First meeting of evaluation. Method of measurement: Based on sex in the information form.</prim_outcome>
      <prim_outcome>Hemodialysis times a week. Timepoint: First meeting of evaluation. Method of measurement: Times number mentions in the information form.</prim_outcome>
      <prim_outcome>The duration of arteriovenous fistula. Timepoint: First meeting of evaluation. Method of measurement: Based on year and month in the information form.</prim_outcome>
      <prim_outcome>Arteriovenous fistula site. Timepoint: First meeting of evaluation. Method of measurement: Site mentions in the information form.</prim_outcome>
      <prim_outcome>History of previous AVF. Timepoint: First meeting of evaluation. Method of measurement: Yes or no mentions in the information form.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Qazvin University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2013-07-10</approval_date>
        <contact_name>Ethics Committee of Qazvin University of Medical Sciences</contact_name>
        <contact_address>Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin Qazvin  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
